Carrie Maynard

Carrie Maynard is Associate Director, Biopharma Segment at Oxford Nanopore Technologies. She works with biopharma organisations across discovery, development and quality control, supporting the application of nanopore sequencing within drug development workflows. With nine years of experience working closely with the biopharma sector, she has developed expertise in the scientific and operational challenges associated with bringing new therapies from research through to quality control.